Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1' H)-triones for treatment of conditions associated with vanilloid receptor 1

Details for Australian Patent Application No. 2007212786 (hide)

International Classifications

Event Publications

21 August 2008 PCT application entered the National Phase

PCT publication WO2007/091947 Priority application(s): WO2007/091947

6 May 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name AstraZeneca AB, Application No. 2007212786, under INID (54) correct the title to read Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'H)-triones for treatment of conditions associated with vanilloid receptor 1

2 June 2011 Application Accepted

Published as AU-B-2007212786

29 September 2011 Standard Patent Sealed

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.